Mobile navigation menu modal
Our thought leaders and specialist consultants have a wealth of case studies, news, and blog articles to check out.
Clinical trial sponsor and site engagement communication pathways lay the foundation for study performance and data outcomes. In this insight, Blair S
In the high-stakes world of clinical trials, risk management isn’t just a regulatory checkbox, it’s the backbone of scientific integrity and operation
As summer of 2025 begins, it is reasonable to contemplate the extreme impact of substantial growth with general remote activities within in recent yea
Recruiting participants for clinical trials is a crucial aspect of advancing medical research, but when it comes to...
The traditional "one-size-fits-all" concept is shifting towards a more customized approach in personalized or precision medicine (PM),
Introduction Let’s face it: “Omnichannel”, as a term, is overused. We’re all tired of it. Especially in...
Randomized controlled trials often have restrictive inclusion criteria, resulting in trial participants who do not represent the real-world population
Introduction As the cornerstone of advancing medical science, clinical trials require broad diversity among...
Matt Lewis, the Global Chief Officer for Artificial and Augmented Intelligence at Inizio Medical, has been featured alongside Richard Graves from...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical, took part in a recent podcast with CPO playbook regarding...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical has joined a recent discussion on GOLD’s ‘2024 pharma...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical, contributed to a recent piece in the Current Medical...
